TY - JOUR
T1 - Nonpharmacologic Management of Mixed Dyslipidemia Associated with Diabetes Mellitus and the Metabolic Syndrome
T2 - A Review of the Evidence
AU - Stone, Neil J.
PY - 2008/12/22
Y1 - 2008/12/22
N2 - Patients with type 2 diabetes mellitus or metabolic syndrome typically exhibit atherogenic mixed dyslipidemia characterized by low levels of high-density lipoprotein cholesterol, elevated triglycerides, and an increase in small, dense low-density lipoprotein particles. Treatment guidelines recognize lifestyle intervention as a first step in the management of dyslipidemia in these patients. The aim of this article is to review evidence to support this approach. To achieve all recommended lipid goals in clinical practice, lifestyle intervention is likely to be adjunctive to pharmacotherapy.
AB - Patients with type 2 diabetes mellitus or metabolic syndrome typically exhibit atherogenic mixed dyslipidemia characterized by low levels of high-density lipoprotein cholesterol, elevated triglycerides, and an increase in small, dense low-density lipoprotein particles. Treatment guidelines recognize lifestyle intervention as a first step in the management of dyslipidemia in these patients. The aim of this article is to review evidence to support this approach. To achieve all recommended lipid goals in clinical practice, lifestyle intervention is likely to be adjunctive to pharmacotherapy.
UR - http://www.scopus.com/inward/record.url?scp=58149459488&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58149459488&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2008.09.069
DO - 10.1016/j.amjcard.2008.09.069
M3 - Article
C2 - 19084085
AN - SCOPUS:58149459488
SN - 0002-9149
VL - 102
SP - 14L-18L
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 12 SUPPL.
ER -
